Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Income from Continuing Operations: 2011-2024

Historic Income from Continuing Operations for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $42.0 million.

  • Mimedx Group's Income from Continuing Operations rose 112.59% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year decrease of 52.44%. This contributed to the annual value of $42.0 million for FY2024, which is 37.72% down from last year.
  • As of FY2024, Mimedx Group's Income from Continuing Operations stood at $42.0 million, which was down 37.72% from $67.4 million recorded in FY2023.
  • Mimedx Group's Income from Continuing Operations' 5-year high stood at $67.4 million during FY2023, with a 5-year trough of -$49.3 million in FY2020.
  • For the 3-year period, Mimedx Group's Income from Continuing Operations averaged around $29.8 million, with its median value being $42.0 million (2024).
  • In the last 5 years, Mimedx Group's Income from Continuing Operations slumped by 92.67% in 2020 and then spiked by 437.99% in 2023.
  • Mimedx Group's Income from Continuing Operations (Yearly) stood at -$49.3 million in 2020, then surged by 75.04% to -$12.3 million in 2021, then tumbled by 62.21% to -$20.0 million in 2022, then skyrocketed by 437.99% to $67.4 million in 2023, then tumbled by 37.72% to $42.0 million in 2024.